PER 1.23% 8.0¢ percheron therapeutics limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-18

  1. 1,696 Posts.
    lightbulb Created with Sketch. 600
    It’s frustrating yeh but that’s the biotech reality so it needs to be sucked up. It’s similarly frustrating when certain posters pump the shite out of the stock accompanied by lofty short term SP predictions that are exponentially higher than it currently is. That sets an expectation bar that is unrealistic - which in a mining stock would be moderated as “unsubstantiated ramping”. Hence the apparent disappointment.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.